UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine

The journal of clinical psychiatry, 2006-05, Vol.67 (5), p.771

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of pregabalin in the treatment of generalized anxiety disorder : Double-blind, placebo-controlled comparison of BID versus TID dosing

Journal of clinical psychopharmacology, 2005-04, Vol.25 (2), p.151-158

2005

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy of pregabalin in generalized anxiety disorder

International clinical psychopharmacology, 2008-01, Vol.23 (1), p.18

2008

Link zum Volltext

Verfügbarkeit prüfen

Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial

The American journal of psychiatry, 2003-03, Vol.160 (3), p.533-540

2003

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: A placebo-controlled, multicenter study

Journal of clinical psychopharmacology, 2004-04, Vol.24 (2), p.141-149

2004

Link zum Volltext

Verfügbarkeit prüfen

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy

Bipolar disorders, 2000-10, Vol.2 (3p2), p.249-255

2000

Link zum Volltext

Verfügbarkeit prüfen

Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder

Biological psychiatry (1969), 1999-09, Vol.46 (6), p.860-862

1999

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study of Pregabalin in Patients With Generalized Anxiety Disorder

Journal of clinical psychopharmacology, 2003-06, Vol.23 (3), p.240-249

2003

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder

Journal of clinical psychopharmacology, 2003-06, Vol.23 (3), p.240-249

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics of patients with concurrent major depressive disorder and panic disorder

The American journal of psychiatry, 1994-04, Vol.151 (4), p.541-546

1994

Link zum Volltext

Verfügbarkeit prüfen

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam

Archives of general psychiatry, 2005-09, Vol.62 (9), p.1022

2005

Link zum Volltext

Verfügbarkeit prüfen

Treatment of social phobia with gabapentin : A placebo-controlled study

Journal of clinical psychopharmacology, 1999-08, Vol.19 (4), p.341-348

1999

Link zum Volltext

Verfügbarkeit prüfen

Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain

Clinical neuropharmacology, 1996-10, Vol.19 (5), p.451-456

1996

Link zum Volltext

Verfügbarkeit prüfen

Placebo-controlled study of gabapentin treatment of Panic disorder

Journal of clinical psychopharmacology, 2000-08, Vol.20 (4), p.467-471

2000

Link zum Volltext

Verfügbarkeit prüfen

Two year follow-up of atypical depression

Journal of psychiatric research, 1999-01, Vol.33 (1), p.23-29

1999

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological treatments of SAD

Canadian journal of psychiatry, 1990-11, Vol.35 (8), p.721

Pande, A C

1990

Link zum Volltext

Verfügbarkeit prüfen

Fluoxetine versus phenelzine in atypical depression

Biological psychiatry (1969), 1996-11, Vol.40 (10), p.1017-1020

1996

Link zum Volltext

Verfügbarkeit prüfen

Sleep Electroencephalographic Studies After ECT: Age and Clinical Response

The American journal of geriatric psychiatry, 1994, Vol.2 (1), p.39-51

1994

Link zum Volltext

Verfügbarkeit prüfen

Sublingual lorazepam use

Canadian journal of psychiatry, 1987-05, Vol.32 (4), p.328

Pande, A C

1987

Link zum Volltext

Verfügbarkeit prüfen

Effect of gabapentin (neurotonin ®) on mood and well-being in patients with epilepsy

Progress in neuro-psychopharmacology & biological psychiatry, 1996-04, Vol.20 (3), p.407-417

1996

Link zum Volltext

Verfügbarkeit prüfen

A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder

Journal of clinical psychopharmacology, 1995-12, Vol.15 (6), p.428-434

1995

Link zum Volltext

Verfügbarkeit prüfen

The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients

Psychopharmacology, 1997-02, Vol.129 (3), p.243-248

1997

Link zum Volltext

Verfügbarkeit prüfen

Gabapentin in bipolar disorder: a placebo‐controlled trial of adjunctive therapy1

Bipolar disorders, 2000-10, Vol.2 (3p2), p.249-255

2000

Link zum Volltext

Verfügbarkeit prüfen

Analgesic efficacy of the κ-receptor agonist, enadoline, in dental surgery pain

Clinical neuropharmacology, 1996-02, Vol.19 (1), p.92-97

1996

Link zum Volltext

Verfügbarkeit prüfen

Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder

Psychiatry research, 1999-03, Vol.85 (3), p.225-240

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(48)
Science & Technology
(48)
Psychiatry
(41)
Humans
(40)
Biological And Medical Sciences
(34)
Medical Sciences
(34)
Adult
(33)
Female
(33)
Male
(33)
Psychology. Psychoanalysis. Psychiatry
(31)
Middle Aged
(27)
Psychopathology. Psychiatry
(19)
Neuropharmacology
(18)
Pharmacology. Drug Treatments
(18)
Double-Blind Method
(16)
Neurosciences & Neurology
(15)
Psychopharmacology
(14)
Neurosciences
(13)
Pharmacology & Pharmacy
(13)
Depressive Disorder - Psychology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine

Efficacy of pregabalin in the treatment of generalized anxiety disorder : Double-blind, placebo-controlled comparison of BID versus TID dosing

Long-term efficacy of pregabalin in generalized anxiety disorder

Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial

Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: A placebo-controlled, multicenter study

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy

Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder

A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study of Pregabalin in Patients With Generalized Anxiety Disorder

A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder

Clinical characteristics of patients with concurrent major depressive disorder and panic disorder

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam

Treatment of social phobia with gabapentin : A placebo-controlled study

Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain

Placebo-controlled study of gabapentin treatment of Panic disorder

Two year follow-up of atypical depression

Pharmacological treatments of SAD

Fluoxetine versus phenelzine in atypical depression

Sleep Electroencephalographic Studies After ECT: Age and Clinical Response

Sublingual lorazepam use

Effect of gabapentin (neurotonin ®) on mood and well-being in patients with epilepsy

A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder

The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients

Gabapentin in bipolar disorder: a placebo‐controlled trial of adjunctive therapy1

Analgesic efficacy of the κ-receptor agonist, enadoline, in dental surgery pain

Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder

Suchergebnisse filtern